Variant report
Variant | esv3381861 |
---|---|
Chromosome Location | chr4:81587822-81608017 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs7693520 | chr4:81599070-81599071 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs529944240 | chr4:81599224-81599225 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs185202392 | chr4:81599233-81599234 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs546451561 | chr4:81599235-81599236 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs566422788 | chr4:81599274-81599275 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs557730136 | chr4:81599326-81599327 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs189882111 | chr4:81599347-81599348 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs77925317 | chr4:81599350-81599351 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs572392115 | chr4:81599371-81599372 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs182457406 | chr4:81599377-81599378 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs185409640 | chr4:81599434-81599435 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs11733929 | chr4:81599437-81599438 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs75042231 | chr4:81599533-81599534 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs547779188 | chr4:81599537-81599538 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs140758973 | chr4:81599544-81599545 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs533493921 | chr4:81599558-81599559 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs138595151 | chr4:81599587-81599588 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs549954093 | chr4:81599612-81599613 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs189481052 | chr4:81599705-81599706 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs138921390 | chr4:81599763-81599764 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs535511590 | chr4:81599795-81599796 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs555141520 | chr4:81599808-81599809 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs565784021 | chr4:81599815-81599816 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs550520837 | chr4:81599891-81599892 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs180835402 | chr4:81599913-81599914 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs61372633 | chr4:81599919-81599920 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs577995067 | chr4:81599942-81599943 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs185621572 | chr4:81599945-81599946 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs144615985 | chr4:81600074-81600075 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs190034715 | chr4:81600089-81600090 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs376415817 | chr4:81600174-81600175 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs79628494 | chr4:81600230-81600231 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs562003771 | chr4:81600244-81600245 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs567147521 | chr4:81600270-81600271 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs572505985 | chr4:81600314-81600315 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs534187797 | chr4:81600320-81600321 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs541066574 | chr4:81600335-81600336 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs564182320 | chr4:81600339-81600340 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs369703793 | chr4:81600396-81600397 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs181625727 | chr4:81600411-81600412 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs539486726 | chr4:81600424-81600425 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs72864815 | chr4:81600426-81600427 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs529429727 | chr4:81600427-81600428 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs187046167 | chr4:81600436-81600437 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs565591766 | chr4:81600441-81600442 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs138504889 | chr4:81600537-81600538 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs142254056 | chr4:81600596-81600597 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs571292880 | chr4:81600607-81600608 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs537067397 | chr4:81600627-81600628 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs557325087 | chr4:81600752-81600753 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 17603634 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Parkinson disease | 21956041 | CNVD |
Mental retardation | 20522426 | CNVD |
delayed speech | 20522426 | CNVD |
growth disorder | 20522426 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Parkinson disease | 18923514 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16272173 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Lung cancer | 19208797 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21785460 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Multiple myeloma | 17550852 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Cancer | 22429812 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Autism | 18414403 | CNVD |
Chronic lymphocytic leukemia | 21670202 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Gastric cancer | 16891809 | CNVD |
Prostate cancer | 16573809 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
abnormal development | 18461090 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:81599000-81599800 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
2 | chr4:81599000-81601200 | Enhancers | Primary T cells from cord blood | blood |
3 | chr4:81599600-81600200 | Enhancers | Primary T helper naive cells fromperipheralblood | blood |
4 | chr4:81599600-81600400 | Enhancers | Primary T killer naive cells fromperipheralblood | blood |
5 | chr4:81600200-81601200 | Weak transcription | Primary T helper naive cells fromperipheralblood | blood |
6 | chr4:81601200-81601400 | Enhancers | Primary T helper naive cells fromperipheralblood | blood |